search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
EDITORS VOICE


Editorial Editor Sarah Robinson sarah@opusbm.co.uk


Editor Ryan Lloyd ryan@opusbm.co.uk


Advertising Account Manager Paul Turner paul@opusbm.co.uk


Production Production Director Hannah Wilkinson hannah@opusbm.co.uk


Designer Daniel Etheridge daniel@opusbm.co.uk


Designer Nigel Rice nigel@opusbm.co.uk


CEO Mark Hanson mark@opusbm.co.uk


www.tomorrowshs.com


E: info@opusbusinessmedia.co.uk T: 01625 426054 Opus Business Media Ltd


A happy new year to all our readers as we welcome you to the January issue of Tomorrow’s Health and Safety.


As all four UK nations find themselves in a third lockdown of some sorts, it feels for many as though we are in a similar predicament to the one we found ourselves in in March 2020. The new variant identified in December has stormed through London and the South East, and at the time of writing, there are warnings that some of London’s hospitals may be overwhelmed in the next fortnight.


Despite this awfully grim outlook, there is a lighthouse in the storm. The UK has now officially given approval to two vaccines (Pfitzer BioNTech and Oxford AstraZeneca) with a rollout that began in December. Prime Minister Boris Johnson has set a target of two million doses to be delivered to the elderly and clinically vulnerable per week over the next month and a half. We should know over the course of the next fortnight whether that target is reachable.


The sooner the more vulnerable sections of the population have been vaccinated, the sooner the country has the opportunity to return to some form of normality, although the virus itself has become endemic and will circulate like any other seasonal virus for years and decades to come.


It all happened at once of course, as these things tend to. Whilst the government grappled with a COVID-19 second wave, the UK/EU transition period also came to an end on 31 December. With it brings a host of changes. In this issue, Satra takes a look at one of these changes: a move away from the European CE mark for PPE towards the United Kingdom Conformity Assessed (UKCA) Mark. You can find out more on page 30.


Elsewhere, we look at Noise Monitoring & Acoustic Solutions, Working at Height and Floor Safety. We also have a round-up of the latest news and recent product launches. It’s good to have you all back with us.


Zurich House, Hulley Road, Macclesfield, Cheshire SK10 2SF Registered in England & Wales No: 06786728


ISSN: 2055-4737


This publication is copyright Opus Business Media Ltd and may not be reproduced or transmitted in any form in whole or in part without the prior written permission of Opus Business Media Ltd. While every care has been taken during the preparation of this magazine, Opus Business Media Ltd cannot be held responsible for the accuracy of the information herein or for any consequence arising from it. The publisher does not necessarily agree with the views and opinions expressed by contributors.


4 Enjoy the issue. EDITOR’S VOICE


FOLLOW US ON TWITTER @TOMORROWSHS Ryan Lloyd, Editor


Sarah Robinson, Editor www.tomorrowshs.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60